Van Leeuwenhoeck Issues Updated Addex Equity Research Report Swiss Stock Exchange:ADXN
Geneva, Switzerland, July 20, 2020 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development today announced that the independent life science equity research company, Van...








